NeuroStar® Patient Outcomes Registry Has Now Surpassed 3000 Evaluable Patients, Making It The World's Largest in Major Depressive Disorder - P&T Community

Submitted by Anonymous (not verified) on Mon, 07/08/2019 - 11:30

NeuroStar® Patient Outcomes Registry Has Now Surpassed 3000 Evaluable Patients, Making It The World's Largest in Major Depressive Disorder  P&T CommunityMALVERN, Pa., July 8, 2019 /PRNewswire/ -- Neuronetics, Inc. (NASDAQ: STIM) – Neuronetics, Inc., the developer of NeuroStar® Advanced Therapy, ...